Cargando…

Immunological Evaluation and Comparison of Different EV71 Vaccine Candidates

Enterovirus 71 (EV71) and coxsackievirus A16 (CVA16) are major causative agents of hand, foot, and mouth diseases (HFMDs), and EV71 is now recognized as an emerging neurotropic virus in Asia. Effective medications and/or prophylactic vaccines against HFMD are not available. The current results from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chou, Ai-Hsiang, Liu, Chia-Chyi, Chang, Jui-Yuan, Lien, Shu-Pei, Guo, Meng-Shin, Tasi, Hau-Pong, Hsiao, Kuang-Nan, Liu, Shih-Jen, Sia, Charles, Wu, Suh-Chin, Lee, Min-Shi, Hsiao, Chia-Hsin, Wang, Jen-Ren, Chow, Yen-Hung, Chong, Pele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3447357/ https://www.ncbi.nlm.nih.gov/pubmed/23008736 http://dx.doi.org/10.1155/2012/831282

Ejemplares similares

Production of EV71 vaccine candidates
por: Chong, Pele, et al.
Publicado: (2012)

Human SCARB2-Mediated Entry and Endocytosis of EV71
por: Lin, Yi-Wen, et al.
Publicado: (2012)

Delivery of Human EV71 Receptors by Adeno-Associated Virus Increases EV71 Infection-Induced Local Inflammation in Adult Mice
por: Hsiao, Hung-Bo, et al.
Publicado: (2014)

Immunogenicity Studies of Bivalent Inactivated Virions of EV71/CVA16 Formulated with Submicron Emulsion Systems
por: Lin, Chih-Wei, et al.
Publicado: (2014)

Human SCARB2 Transgenic Mice as an Infectious Animal Model for Enterovirus 71
por: Lin, Yi-Wen, et al.
Publicado: (2013)

Recombinant lipoprotein-based vaccine candidates against C. difficile infections
por: Huang, Jui-Hsin, et al.
Publicado: (2015)

Formalin-Inactivated EV71 Vaccine Candidate Induced Cross-Neutralizing Antibody against Subgenotypes B1, B4, B5 and C4A in Adult Volunteers
por: Chou, Ai-Hsiang, et al.
Publicado: (2013)

Immunological and Biochemical Characterization of Coxsackie Virus A16 Viral Particles
por: Chong, Pele, et al.
Publicado: (2012)

The mature EV71 virion induced a broadly cross-neutralizing VP1 antibody against subtypes of the EV71 virus
por: Wu, Chia-Ying, et al.
Publicado: (2019)

The uncoating of EV71 in mature late endosomes requires CD-M6PR
por: Ohka, Seii, et al.
Publicado: (2022)

Pilot Scale Production of Highly Efficacious and Stable Enterovirus 71 Vaccine Candidates
por: Chou, Ai-Hsiang, et al.
Publicado: (2012)

Long-Term Immunogenicity Studies of Formalin-Inactivated Enterovirus 71 Whole-Virion Vaccine in Macaques
por: Liu, Chia-Chyi, et al.
Publicado: (2014)

Recombinant Adeno-Vaccine Expressing Enterovirus 71-Like Particles against Hand, Foot, and Mouth Disease
por: Tsou, Yueh-Liang, et al.
Publicado: (2015)

Purification and Characterization of Enterovirus 71 Viral Particles Produced from Vero Cells Grown in a Serum-Free Microcarrier Bioreactor System
por: Liu, Chia-Chyi, et al.
Publicado: (2011)

Heat Shock protein 90: Role in Enterovirus 71 Entry and Assembly and Potential Target for Therapy
por: Tsou, Yueh-Liang, et al.
Publicado: (2013)

Propagation and immunological characterization of coxsackievirus A10 in a serum-free HEK293A cell culture system
por: Lien, Sheng-Chieh, et al.
Publicado: (2023)

Induction of SOCS Expression by EV71 Infection Promotes EV71 Replication
por: Gao, Wenying, et al.
Publicado: (2020)

Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates
por: Liu, Shih-Jen, et al.
Publicado: (2006)

Challenges to Licensure of Enterovirus 71 Vaccines
por: Lee, Min-Shi, et al.
Publicado: (2012)

Biochemical and Immunological Characterization of Truncated Fragments of the Receptor-Binding Domains of C. difficile Toxin A
por: Huang, Jui-Hsin, et al.
Publicado: (2015)

Honeysuckle Aqueous Extracts Induced let-7a Suppress EV71 Replication and Pathogenesis In Vitro and In Vivo and Is Predicted to Inhibit SARS-CoV-2
por: Lee, Ying-Ray, et al.
Publicado: (2021)

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo
por: Ren, Peijun, et al.
Publicado: (2014)

Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2014)

Plant-Produced Anti-Enterovirus 71 (EV71) Monoclonal Antibody Efficiently Protects Mice Against EV71 Infection
por: Rattanapisit, Kaewta, et al.
Publicado: (2019)

Protective Efficacy of VP1-Specific Neutralizing Antibody Associated with a Reduction of Viral Load and Pro-Inflammatory Cytokines in Human SCARB2-Transgenic Mice
por: Chang, Hsuen-Wen, et al.
Publicado: (2013)

Inhibition of Enterovirus 71 (EV-71) Infections by a Novel Antiviral Peptide Derived from EV-71 Capsid Protein VP1
por: Tan, Chee Wah, et al.
Publicado: (2012)

Flavonoids as Antiviral Agents for Enterovirus A71 (EV-A71)
por: Lalani, Salima, et al.
Publicado: (2020)

Protective effect of enterovirus-71 (EV71) virus-like particle vaccine against lethal EV71 infection in a neonatal mouse model
por: CAO, LEI, et al.
Publicado: (2015)

EV71 vaccine, an invaluable gift for children
por: Liang, Zhenglun, et al.
Publicado: (2014)

Muscle Tissue Damage and Recovery After EV71 Infection Correspond to Dynamic Macrophage Phenotypes
por: Lu, Mei-Yi, et al.
Publicado: (2021)

A clinically authentic mouse model of enterovirus 71 (EV-A71)-induced neurogenic pulmonary oedema
por: Victorio, Carla Bianca Luena, et al.
Publicado: (2016)

EV-A71 induced IL-1β production in THP-1 macrophages is dependent on NLRP3, RIG-I, and TLR3
por: Huang, Hsing-I, et al.
Publicado: (2022)

Genomic and immunologic factors associated with viral pathogenesis in a lethal EV71 infected neonatal mouse model
por: YUE, YINGYING, et al.
Publicado: (2016)

Complete Genome Sequence of Human Enterovirus Strain 71 (EV71/Taipei/3118/2011), Isolated from a Patient in Taiwan
por: Lin, Chia-Pei, et al.
Publicado: (2015)

Correction: Phenotypic and Genotypic Characteristics of Novel Mouse Cell Line (NIH/3T3)-Adapted Human Enterovirus 71 Strains (EV71:TLLm and EV71:TLLmv)
Publicado: (2014)

Inhibition of EV71 by curcumin in intestinal epithelial cells
por: Huang, Hsing-I, et al.
Publicado: (2018)

TLR7 Is Critical for Anti-Viral Humoral Immunity to EV71 Infection in the Spinal Cord
por: Lin, Ya-Lin, et al.
Publicado: (2021)

An auto-antibody identified from phenotypic directed screening platform shows host immunity against EV-A71 infection
por: Cheng, Yu-Wei, et al.
Publicado: (2022)

EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge
por: Wang, Xiaowen, et al.
Publicado: (2016)

Mutations in VP1 and 5′-UTR affect enterovirus 71 virulence
por: Chang, Ching-Kun, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k0hift9f7vpn5b745ce33l1rdo